Engineering EVs for Efficient Loading and Targeted Delivery of Antibodies Against Alpha-Synuclein

Full Grant 2024-2025 | Prof. Daniel Offen

 

This project aims to develop a novel Multiple System Atrophy (MSA) treatment using MSC-derived extracellular vesicles to deliver antibodies against alpha-synuclein, neutralizing pathogenic aggregates. 

Next >

 

 

Tel Aviv University makes every effort to respect copyright. If you own copyright to the content contained
here and / or the use of such content is in your opinion infringing Contact us as soon as possible >>
Tel Aviv University, P.O. Box 39040, Tel Aviv 6997801, Israel